Commentary Article on Joint Research Paper with RIKEN Published in eLife
A commentary article on the joint research paper with RIKEN, Robotic search for optimal cell culture in regenerative medicine, published in the British journal eLife on June 28, has been released by the same journal.
Commentary Article
Cell Culture: Implementing robotics and artificial intelligence
An automated platform for cell culture combines robotics and artificial intelligence to optimize cell culture protocols and reliably produce specific cell types that could be used for regenerative medicine treatments.
- Category: Computational and Systems Biology, Stem Cells and Regenerative Medicine
- Published: Jul 20, 2022
- DOI: 10.7554/eLife.80609
- Author: Sujith Sebastian, Clinical Biotechnology Centre, Cellular and Molecular Therapies, NHS Blood and Transplant, United Kingdom
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.